You have 9 free searches left this month | for more free features.

City

Minneapolis (1)

Condition

Epidermolysis Bullosa (2)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 3 (2)

Sponsor

RHEACELL GmbH & Co. KG (2)

Collaborator

Intervention

allo-apz2-ots (2)

placebo (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

allo-apz2-ots

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Epidermolysis Bullosa Trial in Minneapolis (allo-APZ2-OTS, Placebo)

Not yet recruiting

Epidermolysis Bullosa

allo-APZ2-OTS
Placebo

Minneapolis, Minnesota

Masonic Cancer Center and Medical Center Minneapolis

Apr 20, 2023

Epidermolysis Bullosa Trial (allo-APZ2-OTS, Placebo)

Not yet recruiting

Epidermolysis Bullosa

allo-APZ2-OTS
Placebo

(no location specified)

Jul 18, 2022